share_log

Morgan Stanley Maintains Equal-Weight on Evelo Biosciences, Lowers Price Target to $4

Morgan Stanley Maintains Equal-Weight on Evelo Biosciences, Lowers Price Target to $4

摩根士丹利维持对Evelo Biosciences的同等权重,将目标股价下调至4美元
Benzinga Real-time News ·  2022/09/09 08:48

Morgan Stanley analyst Vikram Purohit maintains Evelo Biosciences (NASDAQ:EVLO) with a Equal-Weight and lowers the price target from $5 to $4.

摩根士丹利分析师维克拉姆·普罗希特维持Evelo Biosciences(纳斯达克股票代码:EVLO)的权重持平,并将目标股价从5美元下调至4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发